Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Matrix Metalloproteinases and Diabetic Nephropathy
The clinical trial investigating matrix metalloproteinases in diabetic nephropathy has completed, involving participants with Type 1 diabete…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting [NA]
Sansum Diabetes Research Institute completed an early feasibility study evaluating Zone-MPC and HMS with DiAs for outpatient diabetes manage…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Overnight Type 1 Diabetes Control Under MD-Logic Closed Loop System at the Patient's Home [NA]
A completed clinical trial evaluated overnight glucose control in Type 1 diabetes using the MD-Logic closed-loop system at a patient's home.…
-
CLINICAL_TRIALS withdrawal · 2016-04-08Clinical Trial Update: Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes [Phase 1]
Phase 1 trial of collagen scaffolds loaded with human umbilical cord mesenchymal stem cells for erectile function in men with diabetes has b…
-
FDA approval · 2016-04-07FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for AFREZZA (insulin human) from Mannkind Corporation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: LEA29Y (Belatacept) Emory Edmonton Protocol [Phase 2]
A Phase 2 clinical trial update for belatacept (LEA29Y) under the Emory Edmonton protocol for Type 1 Diabetes Mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: D-chiro-Inositol in Overweight Type 1 Diabetes Patients [Phase 3]
Phase 3 trial evaluating D-chiro-Inositol in overweight individuals with Type 1 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Evolution of Effectiveness of Diabetes Medical Care in Russia
This record notes the completion of a clinical trial in Moscow assessing the evolution of effectiveness of diabetes medical care.
-
FDA approval · 2016-04-05FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot Study [NA]
This pilot clinical trial assessed the impact of a built-in insulin calculator feature on diabetes control in individuals with Type 1 diabet…
-
CLINICAL_TRIALS research · 2016-04-01Clinical Trial Update: Incretin Axis in Type 1 Diabetes Mellitus [NA]
A clinical trial update on the incretin axis in Type 1 Diabetes Mellitus, sponsored by PGIMER Chandigarh; phase and status are not provided.
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes. [NA]
A completed clinical trial evaluating the effect of the beta-2 agonist formoterol on counterregulatory hormonal responses to hypoglycemia in…
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes [Phase 1, Phase 2]
This clinical trial update reports on the pharmacologic response and safety of inhaled insulin in individuals with Type 1 Diabetes, based on…
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: B-Lymphocyte Immunotherapy in Islet Transplantation [Phase 2]
Phase 2 trial evaluating B-Lymphocyte Immunotherapy in islet transplantation for Type 1 Diabetes Mellitus has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes [Phase 2]
Phase 2 trial of peritransplant deoxyspergualin in islet transplantation for Type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus [Phase 1]
Phase 1 study comparing individualized doses of BioChaperone Insulin Lispro with Humalog U-100 in patients with Type 1 Diabetes Mellitus; th…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Post Marketing Surveillance Study of Biphasic Insulin Aspart 30
A post-marketing surveillance study of Biphasic Insulin Aspart 30 has completed.
-
CLINICAL_TRIALS research · 2016-03-07Clinical Trial Update: Paediatric Subjects - Special Survey
This paediatric special survey sponsored by Novo Nordisk A/S focuses on diabetes in children, covering type 1 and type 2 cases. The study st…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Special Survey for Patients With Type 1 or Type 2 Diabetes
This is a completed clinical trial update (Special Survey) sponsored by Novo Nordisk, focusing on patients with Type 1 or Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Special Survey of Production of Insulin Aspart Specific Antibody
A completed special survey evaluating the immune response to insulin aspart by measuring the production of insulin aspart–specific antibodie…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Special Survey for Paediatric Subjects
A special pediatric survey related to diabetes trials sponsored by Novo Nordisk A/S has been completed.
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Special Survey for Type 1 or Type 2 Diabetic Patients
Special survey update for Type 1 and Type 2 diabetes patients sponsored by Novo Nordisk A/S; the trial status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial update evaluating the safety of insulin detemir in insulin-dependent Type 1 and Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction
A completed Novo Nordisk-sponsored trial evaluating how initiating or switching to insulin detemir affects emotional well-being and treatmen…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes
A completed trial evaluated Levemir (insulin detemir) in patients with inadequately controlled Type 1 or Type 2 diabetes. The sponsor was No…